nChroma Bio
A Sr. Scientist LNP Formulation & Process Development at nChroma Bio contributes to the development and optimization of Lipid Nanoparticle (LNP) formulations and collaborates with internal teams and external partners to support multiple research and development programs.
nChroma Bio is a genetic medicines company based in Boston that takes a disease-first approach to therapeutic design. The company combines best-in-class genetic cargoes with targeted in vivo delivery technologies to develop potent and durable treatments addressing areas of high unmet need. nChroma Bio operates in the biotechnology industry with a focus on overcoming the limitations of current gene therapy approaches.
Genetic medicine outfit nChroma sheds staff in research reorg
Nov 12, 2025
nChroma Bio clears first clinical hurdle for CRISPR-based epigenetic HBV therapy
Dec 17, 2025
nChroma Bio Receives Authorization of Clinical Trial Application to Initiate First-in-Human Study for Epigenetic Silencer CRMA-1001 for the Treatment of Chronic Hepatitis B
Dec 16, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for nChroma Bio.
24% above the average for this role
nChroma Bio Presents Preclinical Data Demonstrating Epigenetic Silencing Approach as a Potential Functional Cure for Chronic Hepatitis B at AASLD 2025
Nov 10, 2025
LNP Scientist
ElevateBio
Principal Scientist, LNP Platform & Process Development (Scientist)
Tr1X
LNP Senior Scientist
ElevateBio
Scientist, LNP Formulations
Flagship Pioneering, Inc.
Scientist, LNP Process and Development
Flagship Pioneering, Inc.
Research Associate, LNP Formulations
Flagship Pioneering, Inc.